This segment encompasses the operation of over 520 pharmacies under the Amavita, Sun Store, and Coop Vitality brands, providing a comprehensive range of healthcare products and services directly to consumers. It includes the distribution of medications for home treatment, along with a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products. The segment also offers marketing and sales services to healthcare partners, leveraging its extensive network and market expertise. Research and development efforts focus on expanding the product portfolio and enhancing service offerings to meet evolving patient needs. The segment aims to improve patient access to essential healthcare products and services, contributing to better health outcomes and overall well-being. Future opportunities include expanding the pharmacy network, enhancing e-commerce capabilities, and developing innovative healthcare solutions.

The Logistics & IT segment provides specialized pre-wholesale services to pharmaceutical and healthcare companies, including storage, distribution, and debt collection. It offers comprehensive logistics and IT solutions, including a master data system tailored for the healthcare market. The segment develops management solutions for healthcare providers and publishes technical information on pharmaceutical products in both printed and electronic formats. Research and development activities focus on optimizing logistics processes, enhancing IT infrastructure, and developing innovative management tools for pharmacies. The segment aims to improve efficiency and reduce costs for its clients, ensuring the reliable and timely delivery of healthcare products. Future opportunities include expanding its IT service offerings, developing advanced data analytics capabilities, and leveraging technology to improve supply chain management.

This segment focuses on diagnostic services through the acquisition of Labor Team Group. The segment aims to strengthen Galenica's healthcare network and innovation by providing a range of diagnostic services. Research and development activities will focus on expanding the diagnostic capabilities, improving testing methodologies, and integrating diagnostic data with existing healthcare services. The segment aims to improve patient outcomes through early and accurate diagnosis, contributing to better treatment decisions and overall healthcare management. Future opportunities include expanding the range of diagnostic tests offered, developing personalized diagnostic solutions, and leveraging technology to improve the accessibility and efficiency of diagnostic services.